Authors
Latest:
Salt, Ticks, and Lyme: A Case of Lyme Neuroborreliosis Presenting as SIADHThis case report is the fourth documented case of Lyme-induced syndrome of inappro­priate secretion of antidiuretic hormone (SIADH).
Latest:
Key Takeaways on Managing Antimicrobial Resistant Gram-Negative InfectionsChristian Sandrock, MD, MPH, FCCP, shares key takeaways on the antimicrobial resistant gram-negative infection space from ID week 2023.
Latest:
Carriage of ESBL-PE May Increase the Risk of Colorectal Surgical Site InfectionsIs it time to screen for these bacteria and modify colorectal surgical prophylaxis?
Latest:
An Unusual Case of Testicular Swelling in a Patient With HIVBeing immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.
Latest:
Can Drinking Coffee Boost Survival Rates Among HIV/HCV Co-Infected Patients?The results of a 5-year study show that coffee drinking can cut down the risk of all-cause mortality in patients with HIV and hepatitis C virus (HCV) infections.
Latest:
Border Patrol Stance on Flu Vaccines Mobilizes ID CommunityThree children in US Customs and Border Protection custody have died since December 2018, partially due to influenza. Now, the infectious disease community is rallying for vaccination for migrants in detention facilities.
Latest:
Bringing Culture-Independent Diagnostic Tests for Bloodstream Infections Into Rational Patient ManagementThese tests have the potential to transform patient care and antimicrobial stewardship, but they have not gained widespread acceptance, partly because of uncertainty over how to use them clinically.
Latest:
Influenza Triggers Immune Responses Resulting in Relapse in Patients with Multiple SclerosisA recent study investigates what causes relapse in those with multiple sclerosis and sought to glean insight into the brain activity of patients with MS during respiratory infections.
Latest:
Controversies in C Difficile PreventionNicola Petrosillo, MD, discusses current controversies in C difficile prevention and treatment.
Latest:
The Search for HIV-Associated Neurocognitive Disorder BiomarkersA recent commentary discusses the need to uncover diagnostic and prognostic biomarkers for HIV-associated neurocognitive disorder (HAND).
Latest:
What is on the Horizon for HIV Prevention?A new review in The Lancet HIV discusses the next generation of HIV prevention, called PrEP 2.0.
Latest:
A Look Into the Antimicrobial Stewardship Collaborative of South CarolinaProviders in other states can learn from this multiorganization collaborative that aims to improve antimicrobial utilization and prevent the emergence of antimicrobial resistance across South Carolina.
Latest:
Maintaining Patient Safety During a Water Intrusion in the ORHealth workers had to act quickly when 30,000 gallons of water spilled into the operating room of a level 1 trauma center in Texas.
Latest:
An Update on LenacapavirThis new antiretroviral with a unique mechanism of action may be lifesaving for those with treatment-resistant HIV infection.
Latest:
Researchers Find Drug Combo Works Against Multidrug-Resistant BacteriaRecent research has found that a surprising drug combo might be the key to fighting multidrug-resistant bacteria.
Latest:
Risk for Cancer-Causing Infections Highest in Low- and Middle-Income CountriesDespite the progress that has been made, more research is needed on cancer prevention, hepatitis B, and human papillomavirus vaccines.
Latest:
RSV Roundtable: Disease Education, Vaccine Hesitancy, and AwarenessIn the second installment of the RSV Roundtable, our panel explains how they are educating patients and parents when it comes to RSV, vaccines and preventive measures, and limited treatment availability.
Latest:
Can Infectious Disease Physicians Help Prevent Violence?About 1.6 million individuals die from violence each year on a global scale—do infectious disease physicians have a role in preventing it?
Latest:
A "Bottom Up" Treatment for Ebola That Could Have Been Used in West AfricaAs sporadic cases of Ebola continue to arise in West Africa, a controversial approach could be utilized to increase survival rates in those who are infected.
Latest:
Treating Outpatient Cystitis in the Era of Antimicrobial ResistanceWhat can clinicians do now that increasing resistance has limited oral treatment options for outpatient cystitis?
Latest:
Examining Real-World Evidence for Oritavancin Use in Gram-Positive InfectionsThe challenges of making formulary and clinical decisions based on regulatory studies are significant and the need for real-world clinical experience is increasingly important.
Latest:
Treating Hepatitis C Virus and HIV Coinfections in Intravenous Drug UsersUnique considerations are called for when caring for intravenous drug users with newly diagnosed HIV/HCV coinfections.
Latest:
The Time for Antifungal Stewardship Programs Is NowThe growing threat of resistance and substantial costs for treating these infections accentuates the need for programs focused on appropriate treatment.
Latest:
Two Years After its FDA Approval, Rebyota Continues to Show Efficacy and SafetyPaul Feuerstadt, MD, FACG, AGAF, discusses what the data says as well as offers insights about what patients can expect and medical peer-to-peer information about the procedure.
Latest:
An Unexpected Meningitis CulpritA team of physicians yields surprising findings in an elderly patient in shock with seizures.
